HealthNotableConfirmedDeveloping
8.6
Ryvu Therapeutics and Menarini Group Amend Global Licensing Agreement for Dapolsertib Development
ParkietLO·PL · IT·about 15 hours ago
Lonza is experiencing continued expansion driven by its strategic focus on the pharmaceutical supplier sector. The report confirms a positive growth trajectory for the Basel-based firm, though specific financial metrics or forward-looking guidance remain unquantified in this update.